The Europe Respiratory Devices market is anticipated to add to more than USD 3.28 Billion by 2026-31.

  • Historical Period: 2020-2024
  • Base Year: 2025
  • Forecast Period: 2026-2031
  • Largest Market: Germany
  • Fastest Market: Spain
  • Format: PDF & Excel
Featured Companies
  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • More...

Market Analysis

The European market for breathing machines has changed with the area's healthcare, robust public hospitals, and focus on stopping breathing problems. In the past, Europe's healthcare was quick to use oxygen, breathing machines, and nebulizers. These tools were used in many public hospitals to treat long-term breathing issues like asthma and infections. These devices were very important because of more industry and city pollution, which made breathing problems worse. Breathing machines work by helping with breathing, giving the right amount of oxygen, turning medicine into a mist, or checking how the lungs work. These are key to helping with breathing issues caused by pollution or work. Over time, the machines got better, with better airflow, ways to help patients breathe, and more efficient medicine delivery. It is expected to grow about 6–7% each year for the next ten years. This is because people are getting older and more people have long-term illnesses.

Rules like CE marking and the EU Medical Device Regulation MDR are very important. They keep patients safe, make sure the devices work well, and allow them to be sold across the EU. These certifications help patients and make sure the quality is good. This builds trust and helps the devices be used more in local and markets. According to the research report, " Europe Respiratory Devices Market Research Report, 2031," published by Actual Market Research, the Europe Respiratory Devices market is anticipated to add to more than USD 3.28 Billion by 2026-31. European market for breathing machines is focused on being green, using digital tools, and managing long-term illnesses. Companies are putting money into inhalers that are better for the environment, using less gas. This fits with Europe's goals for green healthcare and a climate-friendly environment. Digital tools, like inhalers that connect to the internet, AI-powered breathing machines, and ways to watch patients from far away, help people follow their treatment, get help early, and avoid going back to the hospital. Big companies like Dräger, Getinge, Philips, and Fisher & Paykel control the market. They have many different products, like breathing machines for serious cases, sleep apnea devices, humidifiers, and home breathing care.

They work with public health systems, make products locally to meet MDR rules, and invest in research and development with money from the EU. There are more chances to grow because Europe's population is getting older, more people are using home care, and the government is supporting ways to prevent illness and use digital treatments. Because of all this, Europe is not just a grown-up market. It is also a leader in new, sustainable, and patient-focused breathing technology. .

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample
Report Sample Preview

Market Dynamic

Market Drivers

• Aging population and pollution-related respiratory diseases: Europe is experiencing a swift rise in its elderly demographic, making individuals more susceptible to lung issues. Prolonged contact with air contaminants leads to an increase in asthma and COPD incidents. Elderly patients need ongoing respiratory assistance and careful observation. Health systems focus on prompt detection and effective disease management. The expanding patient population fuels a consistent demand for respiratory devices. The high incidence of chronic illnesses encourages the use of long-term therapies. This demographic transition supports continued market expansion.

• Strong government-supported healthcare systems: A majority of European nations provide universal healthcare for their citizens. State funding enhances access to respiratory assessments and treatments. Medical facilities, such as hospitals and clinics, receive steady funding for equipment. Preventative healthcare initiatives encourage early intervention for respiratory issues. Public reimbursement facilitates the adoption of long-term treatments. Standardized treatment protocols enhance the use of medical devices. These healthcare frameworks offer market stability and reliable demand. Market Challenges

• Complex EU MDR regulatory framework: The EU Medical Device Regulation MDR has greatly intensified compliance expectations. Producers are encountering more stringent requirements for clinical assessments and documentation. Approval processes are now more time-consuming and intricate. The costs of compliance have increased, especially for smaller firms. Many companies are streamlining their product lines because of regulatory pressures. Delays in obtaining certifications impact product readiness. This poses challenges for entering the market.

• Cost-containment and pricing pressure: Healthcare systems in Europe focus on managing costs and maximizing budgets. Negotiations over prices with public payers shrink profit margins. High-end respiratory devices are adopted more slowly in markets sensitive to costs. Often, hospitals choose standardized, lower-cost alternatives. Competitive bidding places pressure on manufacturers concerning prices. Budget limitations may hinder the adoption of innovative products. Financial pressure continues to be a significant issue. Market Trends

• Sustainable and low-emission respiratory devices: Environmental responsibility is a critical concern in Europe. There is an increasing use of inhalers that have a low warming impact. Manufacturers are modifying their products to lessen their carbon emissions. Regulatory agencies promote the shift towards environmentally friendly devices. Hospitals tend to choose suppliers that offer sustainable options. Patient knowledge supports eco-conscious healthcare decisions. Sustainability is affecting how products are developed.

• Expansion of home-care and digital monitoring: Home respiratory care is growing in various European nations. Digital monitoring aids in managing chronic diseases outside of medical facilities. Connected devices allow for distant oversight by healthcare providers. This approach decreases the strain on hospitals and lowers healthcare expenses. The elderly population tends to prefer receiving treatment at home. Governments are backing care models centered around communities. Digital home care is evolving into a conventional method of treatment.
Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Manmayi Raval
Manmayi Raval

Analyst

Segmentation

By Product Type Therapeutic Devices
Monitoring Devices
Diagnostic Devices
Consumables and Accessories
By Disease Indication Chronic Obstructive Pulmonary disease (COPD)
Sleep Apnea
Asthma
Infectious Diseases
Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)
By End User Hospitals
Ambulatory Care Centers (ACCs)
Home care Settings
Other End User
Europe North America
Europe
Asia-Pacific
South America
MEA



Monitoring tools are the quickest-growing sector in Europe due to the region’s strong focus on early detection, preventive care, and the integration of digital health.

The byproduct Type Monitoring Devices sector is the fastest-growing in the Europe respiratory devices market as European healthcare systems put increasing importance on early diagnosis, ongoing monitoring, and preventive management of respiratory issues. Countries in Europe utilize universal healthcare systems that focus on cost-effective disease management and early treatment to lower hospitalization rates. Respiratory monitoring tools like pulse oximeters, capnography devices, spirometers, and connected monitoring solutions allow healthcare professionals to observe disease development and patient results in real-time. The expanding elderly population and growing rates of pollution-related respiratory illnesses raise the demand for consistent monitoring rather than just therapeutic care. The solid adoption of digital health solutions across Europe allows for the combination of monitoring tools with electronic health records and telehealth platforms, facilitating remote patient management and care at home. Regulatory guidelines and public health efforts promote the use of monitoring instruments to assist in managing chronic illnesses and models of community-based healthcare. Furthermore, monitoring tools tend to be more affordable than complex therapeutic systems, aligning well with Europe’s budget management strategies. An increasing focus on patient-centered care, remote supervision, and sustainable healthcare practices continues to boost their use. Consequently, monitoring tools are witnessing the fastest growth throughout European respiratory care markets.

The fastest growth of sleep apnea is due to increasing obesity levels, greater awareness of screening, and rapid adoption of home-based and connected sleep therapy devices.

Sleep apnea is the most rapidly increasing health issue in the European respiratory devices market as awareness, diagnosis, and treatment are growing quickly throughout the area. Once often missed in diagnoses, sleep apnea is now gaining more clinical focus due to its close links with heart disease, diabetes, and lower quality of life. The rising rates of obesity, inactive lifestyles, and an aging population in Europe have led to a notable rise in those at risk. Meanwhile, public healthcare systems are placing importance on early diagnosis via sleep clinics, home sleep assessments, and primary care screening programs. Devices such as Continuous Positive Airway Pressure CPAP, BiPAP, and AutoPAP continue to be the foundation of treatment, and Europe has experienced a swift increase in the use of smaller, quieter, and more user-friendly devices. This growth is further enhanced by the trend towards home care models, which lessens the burden on hospitals and aligns with the cost-saving approaches of universal healthcare systems. The integration of digital health like cloud-linked CPAP machines, monitoring of compliance, and telehealth follow-ups has boosted adherence to therapy and improved patient results, making treatments more scalable. Supportive reimbursement policies in countries such as Germany, France, and the Nordic nations encourage continued use of devices. Moreover, stringent regulatory oversight through CE marking and compliance with MDR boosts patient confidence and market growth. All these elements together establish sleep apnea as the fastest-growing health segment in Europe’s respiratory devices market.

Home care environments are the quickest expanding end user in Europe due to the decentralization of healthcare, goals for cost savings, and an increasing preference for long-term management of respiratory conditions at home.

Home care environments are emerging as the fastest expanding end-user segment in the European respiratory devices market, driven by a combination of healthcare decentralization, cost-containment strategies, and a growing preference for long-term management of chronic respiratory conditions outside hospital settings. Across Europe, governments and health organizations are actively promoting home-based care to reduce the burden on hospitals and address escalating healthcare expenditures. This shift is particularly evident in the management of conditions such as chronic obstructive pulmonary disease COPD, asthma, and sleep apnea, where patients increasingly rely on advanced respiratory devices like oxygen concentrators, CPAP and BiPAP machines, and portable nebulizers. The aging population further accelerates this trend, as older individuals often prefer the comfort, convenience, and improved quality of life associated with home treatment. Technological innovations have played a pivotal role in enabling this transition, with modern respiratory devices designed to be portable, user-friendly, and digitally connected, allowing for safe and effective therapy in domestic settings. Remote monitoring capabilities integrated into these devices empower healthcare providers to track patient progress, adjust treatment plans, and intervene when necessary, ensuring continuity of care without requiring frequent hospital visits. Moreover, reimbursement frameworks in many European countries support home respiratory care as a cost-efficient alternative to institutional treatment, reinforcing adoption among patients and providers alike. The integration of telemonitoring and digital health solutions not only enhances clinical oversight but also aligns with broader healthcare goals of efficiency, accessibility, and sustainability. These factors position home care settings as the most dynamic and rapidly growing end-user category in Europe’s respiratory devices market.

Market Regional Insights


Germany leads the Europe respiratory devices market thanks to its strong healthcare system, robust medical technology sector, and early integration of advanced respiratory care solutions.

Germany is the foremost country in the Europe respiratory devices market as it is the largest healthcare economy in the area and acts as a key center for manufacturing and innovating medical devices. The nation has a comprehensive healthcare system comprised of extensive hospital networks, specialized centers for lung care, and advanced critical care services. Germany carries a substantial load of chronic respiratory diseases, driven by an older population and high rates of diagnosis, prompting steady demand for respiratory devices. Robust statutory health insurance ensures that many patients can access treatments for respiratory issues, such as ventilators, oxygen therapy units, and devices for sleep apnea. Germany is home to many prominent companies in medical technology and research facilities that invest heavily in the innovation, quality production, and clinical testing of respiratory devices. The early acceptance of digital health technologies and linked medical devices further boosts market expansion. Germany influences EU regulations and clinical standards for medical devices, providing manufacturers with confidence in expanding their products from the German market to the broader European area. Strong export capabilities and a reputation for high-quality engineering reinforce Germany’s leading status in the Europe respiratory devices market.

Companies Mentioned

  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • 7 . Stryker corporation
  • 8 . Siemens AG
  • 9 . GE Healthcare
  • 10 . Vapotherm Inc.
  • 11 . ResMed
  • 12 . Fisher & Paykel Healthcare Corporation Limited
  • 13 . Dragerwerk AG & Co. KGaA
  • 14 . Juki Corporation
  • 15 . Invacare Corporation
  • 16 . Nidek Medical Products Inc.
  • 17 . Teijin Limited
  • 18 . Besco Medical Limited

Table of Contents

  • Table 1: Influencing Factors for Respiratory Devices Market, 2025
  • Table 2: Top 10 Counties Economic Snapshot 2024
  • Table 3: Economic Snapshot of Other Prominent Countries 2022
  • Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
  • Table 5: Europe Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 6: Europe Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 7: Europe Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 8: Germany Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 9: Germany Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 10: United Kingdom (UK) Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 11: United Kingdom (UK) Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 12: France Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 13: France Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 14: Italy Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 15: Italy Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 16: Spain Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 17: Spain Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 18: Russia Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 19: Russia Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 20: Competitive Dashboard of top 5 players, 2025

  • Figure 1: Europe Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 2: Europe Respiratory Devices Market Share By Country (2025)
  • Figure 3: Germany Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 4: United Kingdom (UK) Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 5: France Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 6: Italy Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 7: Spain Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 8: Russia Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 9: Porter's Five Forces of Global Respiratory Devices Market

Market Research FAQs

Factors such as an aging population, increasing cases of respiratory diseases, technological advancements, and a growing awareness of the importance of respiratory care are driving market growth.
Common respiratory care devices include inhalers, nebulizers, oxygen therapy equipment, ventilators, and positive airway pressure (PAP) devices like CPAP and BiPAP machines.
United Kingdom has the largest market share in respiratory care devices.
The COVID-19 pandemic has increased the demand for respiratory care devices, especially ventilators and oxygen therapy equipment. It has also highlighted the importance of preparedness for healthcare systems.
Emerging trends may include the development of smart and connected devices, telemedicine solutions for remote monitoring, and increased focus on home healthcare solutions to reduce hospital admissions.
Steady market growth is fueled by universal healthcare systems, increasing air pollution, an aging population, more frequent sleep apnea diagnoses, and rigorous regulatory measures.
CE marking and MDR adherence guarantee the safety and efficacy of devices, facilitating international trade while boosting confidence among patients and healthcare providers.
The segment of sleep apnea is growing the quickest, attributed to rising screening rates, the obesity epidemic, and the growing use of home and digitally connected therapies.
Manufacturers are increasingly creating environmentally friendly inhalers, energy-efficient products, and sustainable production methods to align with Europe’s healthcare and environmental goals.

Why Actual Market Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology 92%
Data Collection Techniques 97%
Our Research Team & Data Sourcing 93%
Data Science & Analytical Tools 81%
Data Visualization & Presentation Skills 86%
Project/ Report Delivery & After Sales Services 88%

Related Tags